ArticleFrontiers in psychiatry2026
Rapid reduction of suicidal ideation with transient dissociative and "drunken gait" symptoms after intranasal esketamine, with music intervention: a case report.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Treatment-resistant depression (TRD) is often accompanied by persistent suicidal ideation and poor response to conventional antidepressants. Intranasal esketamine, a non-selective NMDA receptor antagonist, provides rapid antidepressant and anti-suicidal effects; transient dissociation is common, whereas ataxia-like "drunken gait" is rarely described. Case presentation: A 19-year-old woman with recurrent depression and multiple prior suicide attempts received two courses of intranasal esketamine (56 and 84 mg, twice weekly for four weeks each). During the first course, she developed transient dissociative symptoms lasting approximately 55 minutes, predominantly characterized by depersonalization and accompanied by a "drunken gait. Under supervision, patient-selected music promptly reduced anxiety and disorientation, improving tolerability. From week 2, prophylactic oxazepam 25 mg prevented mild delayed dissociative episodes. The second course was uneventful. By the end of treatment, suicidal ideation had resolved. Discussion: This case illustrates rapid improvement of depressive symptoms and suicidality with esketamine and shows that dissociative reactions are typically self-limiting and manageable. Music intervention may attenuate these experiences by modulating prefrontal-amygdala circuits and autonomic regulation, thereby reducing anxiety and enhancing reality orientation. Individualized monitoring and psychological support are recommended components of esketamine services. Conclusion: Intranasal esketamine is a promising option for TRD with elevated suicide risk. Patient-selected music is a feasible adjunct to manage dissociative side effects and may improve safety and adherence. Further research should clarify mechanisms and long-term safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.